Integrated BioPharma, Inc. is a well-established biopharma company serving the varied needs of the nutraceutical, biotech and pharmaceutical industries. Through a number of wholly owned subsidiaries INB develops, manufactures and distributes, worldwide over 130 products.
| Revenue (Most Recent Fiscal Year) | $54.35M |
| Net Income (Most Recent Fiscal Year) | $0.81M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.12 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.31 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 2.83 |
| Pre-Tax Margin (Trailing 12 Months) | -2.32% |
| Net Margin (Trailing 12 Months) | -3.43% |
| Return on Equity (Trailing 12 Months) | -8.32% |
| Return on Assets (Trailing 12 Months) | -6.57% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.25 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.78 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 5.07 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.66 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.07 |
| Exchange | NYSE |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Common Shares Outstanding | 30.98M |
| Free Float | 10.10M |
| Market Capitalization | $5.87M |
| Average Volume (Last 20 Days) | 8269.55 |
| Beta (Past 60 Months) | 0.35 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 67.40% |
| Percentage Held By Institutions (Latest 13F Reports) | 25.25% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |